NorthRock Partners LLC Invests $214,000 in Omega Healthcare Investors, Inc. $OHI

NorthRock Partners LLC bought a new position in Omega Healthcare Investors, Inc. (NYSE:OHI) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 5,844 shares of the real estate investment trust’s stock, valued at approximately $214,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Pallas Capital Advisors LLC boosted its holdings in Omega Healthcare Investors by 59.0% in the second quarter. Pallas Capital Advisors LLC now owns 11,915 shares of the real estate investment trust’s stock valued at $437,000 after purchasing an additional 4,420 shares during the last quarter. PFG Investments LLC boosted its holdings in Omega Healthcare Investors by 20.4% in the first quarter. PFG Investments LLC now owns 70,762 shares of the real estate investment trust’s stock valued at $2,695,000 after purchasing an additional 11,970 shares during the last quarter. Asset Management One Co. Ltd. lifted its holdings in Omega Healthcare Investors by 5.0% during the 1st quarter. Asset Management One Co. Ltd. now owns 514,967 shares of the real estate investment trust’s stock worth $19,610,000 after buying an additional 24,640 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its holdings in Omega Healthcare Investors by 556.1% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 1,028,187 shares of the real estate investment trust’s stock worth $39,143,000 after buying an additional 871,472 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in Omega Healthcare Investors by 4.3% during the 1st quarter. Dimensional Fund Advisors LP now owns 4,058,107 shares of the real estate investment trust’s stock worth $154,533,000 after buying an additional 165,554 shares during the last quarter. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Insider Buying and Selling

In related news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm’s stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $40.16, for a total value of $100,400.00. Following the sale, the director directly owned 18,654 shares in the company, valued at $749,144.64. This trade represents a 11.82% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.50% of the stock is currently owned by corporate insiders.

Omega Healthcare Investors Stock Up 1.8%

Shares of Omega Healthcare Investors stock opened at $41.07 on Friday. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96. The business’s 50 day simple moving average is $41.58 and its 200-day simple moving average is $38.88. The stock has a market capitalization of $12.12 billion, a price-to-earnings ratio of 25.35, a PEG ratio of 1.89 and a beta of 0.70. Omega Healthcare Investors, Inc. has a twelve month low of $35.04 and a twelve month high of $44.42.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, topping analysts’ consensus estimates of $0.45 by $0.32. The business had revenue of $235.60 million for the quarter, compared to analysts’ expectations of $248.49 million. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The business’s quarterly revenue was up 11.8% on a year-over-year basis. During the same period in the prior year, the firm earned $0.71 EPS. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Equities research analysts forecast that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current year.

Omega Healthcare Investors Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Monday, August 4th were given a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 6.5%. The ex-dividend date was Monday, August 4th. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 165.43%.

Analyst Ratings Changes

A number of research analysts have commented on the company. Scotiabank increased their target price on Omega Healthcare Investors from $39.00 to $42.00 and gave the stock a “sector perform” rating in a report on Thursday, August 28th. Truist Financial increased their target price on Omega Healthcare Investors from $39.00 to $44.00 and gave the stock a “hold” rating in a report on Wednesday, September 3rd. Cantor Fitzgerald assumed coverage on Omega Healthcare Investors in a report on Wednesday, October 1st. They set an “overweight” rating and a $50.00 target price on the stock. Wells Fargo & Company increased their target price on Omega Healthcare Investors from $41.00 to $44.00 and gave the stock an “overweight” rating in a report on Wednesday, August 27th. Finally, Mizuho increased their target price on Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a “neutral” rating in a report on Thursday, September 11th. Six analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $44.38.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.